Rosendaal FR - Search Results

1

Platelet count and the risk for thrombosis and death in the elderly.

van der Bom JG, Heckbert SR, Lumley T, Holmes CE, Cushman M, Folsom AR, Rosendaal FR, Psaty BM. van der Bom JG, et al. Among authors: rosendaal fr. J Thromb Haemost. 2009 Mar;7(3):399-405. doi: 10.1111/j.1538-7836.2008.03267.x. Epub 2008 Dec 20. J Thromb Haemost. 2009. PMID: 19143922 Free PMC article.

2

Mortality and causes of death in Dutch haemophiliacs, 1973-86.

Rosendaal FR, Varekamp I, Smit C, Bröcker-Vriends AH, van Dijck H, Vandenbroucke JP, Hermans J, Suurmeijer TP, Briët E. Rosendaal FR, et al. Br J Haematol. 1989 Jan;71(1):71-6. doi: 10.1111/j.1365-2141.1989.tb06277.x. Br J Haematol. 1989. PMID: 2917132

3

The risk of myocardial infarction associated with antihypertensive drug therapies.

Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, et al. Psaty BM, et al. Among authors: rosendaal fr. JAMA. 1995 Aug 23-30;274(8):620-5. JAMA. 1995. PMID: 7637142 Free article.

4

Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness.

Sosef MN, Bosch JG, van Oostayen J, Visser T, Reiber JH, Rosendaal FR. Sosef MN, et al. Among authors: rosendaal fr. Thromb Haemost. 1994 Aug;72(2):250-4. Thromb Haemost. 1994. PMID: 7831661

5

Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).

Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Koster T, et al. Among authors: rosendaal fr. Thromb Haemost. 1994 Jun;71(6):719-22. Thromb Haemost. 1994. PMID: 7974338

6

Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect.

Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E. Allaart CF, et al. Among authors: rosendaal fr. Lancet. 1993 Jan 16;341(8838):134-8. doi: 10.1016/0140-6736(93)90003-y. Lancet. 1993. PMID: 8093743

7

A method to determine the optimal intensity of oral anticoagulant therapy.

Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. Rosendaal FR, et al. Thromb Haemost. 1993 Mar 1;69(3):236-9. Thromb Haemost. 1993. PMID: 8470047

8

Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.

Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Bertina RM, et al. Among authors: rosendaal fr. Thromb Haemost. 1995 Jul;74(1):449-53. Thromb Haemost. 1995. PMID: 8578504 Review.

9

[Calcium antagonists: safe or unsafe?].

Rosendaal FR, Psaty BM, Furberg CD. Rosendaal FR, et al. Ned Tijdschr Geneeskd. 1996 Apr 27;140(17):916-8. Ned Tijdschr Geneeskd. 1996. PMID: 8676969 Dutch. No abstract available.

10

Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.

van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA. van Boven HH, et al. Among authors: rosendaal fr. Thromb Haemost. 1996 Mar;75(3):417-21. Thromb Haemost. 1996. PMID: 8701400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,177 results

Search Page

Filters